Skyrizi 180 mg, Injektionslösung in einer Patrone für ein Dosiergerät
7680689460024
CH-68946
L04AC18
07.15.0.
Reimbursement limitations:
SKYRIZI_360
Maladie de Crohn (dosages à 360 mg et 600 mg)
Seuls des médecins spécialistes en …
1 / 2
google
Details
- Product number
- 6894602
- CPT
- -
- Packaging group
- 1
- Unit
- Stück
- Composition
- risankizumabum 180 mg, natrii acetas trihydricus corresp. natrium 0.25 mg, acidum aceticum glaciale, trehalosum dihydricum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1.2 ml.
Articles (1)
Skyrizi 180 mg, Injektionslösung in einer Patrone für ein Dosiergerät
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
180.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.25 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 2343.30
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/10/2025
Authorization holder
AbbVie AG
6330 Cham
Authorization information
- Swissmedic authorization number
- 68946
- Drug name
- Skyrizi, Injektionslösung in einer Patrone für ein Dosiergerät
- Galenic form
- LSILPD
- ATC Code
- L04AC18
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 14/09/2023
- Authorization expiration date
- 13/09/2028
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SKYRIZI sol inj 180 mg 1 pce
- Description (DE)
- SKYRIZI Inj Lös 180 mg 1 Stk
- Market launch
- 14/02/2025
- Market withdrawal
- 13/09/2028
- Narcotic (BTM)
- No